adx 102 Search Results


adx-102 1% (reproxalap)  (Aldeyra Therapeutics)
90
Aldeyra Therapeutics adx-102 1% (reproxalap)
Current and recently completed registered clinical trials, awaiting for results to be published
Adx 102 1% (Reproxalap), supplied by Aldeyra Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/adx-102 1% (reproxalap)/product/Aldeyra Therapeutics
Average 90 stars, based on 1 article reviews
adx-102 1% (reproxalap) - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier
adx-102  (Aladdin Scientific Corporation)
N/A
InformationADX-102 (NS-2) is a free aldehyde trapper potentially useful in the treatment of inflammation, uveitis, and fatty aldehyde dehydrogenase deficiency.
   Buy from Supplier
adx-102  (Selleck Chemicals)
N/A
ADX-102 (NS-2) is a free aldehyde trapper potentially useful in the treatment of inflammation, uveitis, and fatty aldehyde dehydrogenase deficiency.
   Buy from Supplier

Image Search Results


Current and recently completed registered clinical trials, awaiting for results to be published

Journal: Orphanet Journal of Rare Diseases

Article Title: New developments in the molecular treatment of ichthyosis: review of the literature

doi: 10.1186/s13023-022-02430-6

Figure Lengend Snippet: Current and recently completed registered clinical trials, awaiting for results to be published

Article Snippet: In 2018, Aldeyra Therapeutics Inc [ ]. announced their phase III randomized double-blind vehicle-controlled trial with topical application of ADX-102 1% (Reproxalap) in SLS patients (NCT03445650), which has now been completed.

Techniques: Clinical Proteomics, Binding Assay, Cream, Protease Inhibitor, Plasmid Preparation, Expressing, Genetically Modified